CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Netflix and CVS Health have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Netflix and CVS Health have been highlighted as Zacks Bull and Bear of the Day
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $61.03 in the latest trading session, marking a +1.73% move from the prior day.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
by Zacks Equity Research
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
by Urmimala Biswas
Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.
Why Is CVS Health (CVS) Up 1.6% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
by Zacks Equity Research
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVS Health (CVS) Expands Food and Beverage Line With New Launch
by Zacks Equity Research
CVS Health's (CVS) Well Market brand offers a blend of mouthwatering flavors and nutritious options, expertly crafted and taste-tested by food enthusiasts.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Pilgrim's and CVS Health have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Pilgrim's and CVS Health have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: CVS Health (CVS)
by Jeremy Mullin
CVS continues to face headwinds amidst growth challenges.
New Strong Sell Stocks for May 6th
by Zacks Equity Research
DDD, ASO and CVS have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2024.
Company News for May 2, 2024
by Zacks Equity Research
Companies In The News Are: CVS, PFE, PPL, ADP.
CVS Health's (CVS) Q1 Earnings Miss Estimates, Margins Up
by Zacks Equity Research
CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.
CVS Health (CVS) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CVS Health (CVS) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of -22.49% and 0.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
CVS Health (CVS) closed at $67.18 in the latest trading session, marking a -0.22% move from the prior day.
Gear Up for CVS Health (CVS) Q1 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Why CVS Health (CVS) Dipped More Than Broader Market Today
by Zacks Equity Research
The latest trading day saw CVS Health (CVS) settling at $67.33, representing a -0.65% change from its previous close.
Earnings Preview: CVS Health (CVS) Q1 Earnings Expected to Decline
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.